Eiger BioPharmaceuticals Current Assets

Eiger BioPharmaceuticals (EIGRQ) currently reports a current assets of $38M as of December 2023. That compares with $120M in the prior-year period — down 67.8% year over year. Use the charts on this page to explore Eiger BioPharmaceuticals's current assets history and peer comparisons.

Eiger BioPharmaceuticals's current assets decreased from $120M to $38M — a 67.8% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Eiger BioPharmaceuticals reported $38M in current assets as of December 2023. That compares with $120M in the prior-year period — down 67.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $38M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Eiger BioPharmaceuticals, and consider following EIGRQ for alerts when major investors trade the stock.

Eiger BioPharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $38M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EIGRQ with unrelated industries.